GLP-1 secretion is stimulated by luminal oleic acid (OA), which crosses the cell membrane by an unknown mechanism. We hypothesized that L cell fatty acid transport proteins (FATPs) are essential for OA-induced GLP-1 release. Therefore, the murine GLUTag L cell model was used for immunoblotting, [3 H]OA uptake assay, and GLP-1 secretion assay as determined by radioimmunoassay following treatment with OA Ϯ phloretin, sulfo-N-succinimidyl oleate, or siRNA against FATP4. FATP4Ϫ/Ϫ and cluster-of-differentiation 36 (CD36) Ϫ/Ϫ mice received intraileal OA, and plasma GLP-1 was measured by sandwich immunoassay. GLUTag cells were found to express CD36, FATP1, FATP3, and FATP4. The cells demonstrated specific 3 H[OA] uptake that was dose-dependently inhibited by 500 and 1,000 M unlabeled OA (P Ͻ 0.001). Cell viability was not altered by treatment with OA. Phloretin and sulfo-N-succinimidyl oleate, inhibitors of protein-mediated transport and CD36, respectively, also decreased [ 3 H]OA uptake, as did knockdown of FATP4 by siRNA transfection (P Ͻ 0.05-0.001). OA dose-dependently increased GLP-1 secretion at 500 and 1,000 M (P Ͻ 0.001), whereas phloretin, sulfo-N-succinimidyl oleate, and FATP4 knockdown decreased this response (P Ͻ 0.05-0.01). FATP4 Ϫ/Ϫ mice displayed lower plasma GLP-1 at 60 min in response to intraileal OA (P Ͻ 0.05), whereas, unexpectedly, CD36 Ϫ/Ϫ mice displayed higher basal GLP-1 levels (P Ͻ 0.01) but a normal response to intraileal OA. Together, these findings demonstrate a key role for FATP4 in OAinduced GLP-1 secretion from the murine L cell in vitro and in vivo, whereas the precise role of CD36 remains unclear.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.